174
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

In vitro and in vivo evaluation of taste-masked orodispersible tablets of fluoxetine hydrochloride for the treatment of depression

, &
Pages 645-653 | Received 30 Sep 2020, Accepted 19 Feb 2021, Published online: 07 Apr 2021

References

  • Ahmed SZ, Bader MA, Mahmoud M, et al. Taste-masked orodispersible tablets of cyclosporine self nanoemulsion lyophilized with dry silica. Pharm Dev Technol. 2014;9(8):1–8.
  • Maha AM, Dina AO, Omnia SM. Studying the effect of different super disintegrants on the in-vitro release of fluoxetine hydrochloride fast dissolving tablets. Int J Pharm Pharm Res. 2020;17(2):238–257.
  • Abay FB., Ugurlu  Orally disintegrating tablets: a short review. J Pharm Drug Dev. 2015;3(3):1–7.
  • Mullen S. Major depressive disorder in children and adolescents. Ment Health Clin. 2018;8(6):275–283.
  • Bharathi A, Mounika B, Tejaswi K, et al. Effect of super disintegrants on the formulation and evaluation of orodispersable tablets of fluoxetine hydrochloride. World J Pharm Pharm Sci. 2018;7(2):1071–1086.
  • Sajal JK. Taste masking in pharmaceuticals an update. J Pharm Res. 2008;1(2):126–130.
  • Mandrioli R, Forti GC, Raggi MA. Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450. Curr Drug Metab. 2006;7(2):127–133.
  • Katewongsa P, Lertsuphotvanit N, Phaechamud T. Cetirizine dihydrochloride, beta-cyclodextrin inclusion complex by ethanol kneading for taste masking. Ind J Pharm Sci. 2017;79(5):758–767.
  • Elkhodairy KA, Hassan MA, Afifi SA. Formulation and optimization of orodispersible tablets of flutamide. Saudi Pharm J. 2014;22(1):53–61.
  • Abd-Elbary A, El Nabarawi1 MA, Ali AM, et al. Formulation and evaluation of taste-masked orally disintegrating tablets of nicergoline based on β-cyclodextrin inclusion complexation. Int J Drug Dev. 2013;5(1):110–120.
  • Meghawati RB, Sandhya LB, Manish SJ, et al. Formulation and evaluation of mouth dissolving tablet of amlodipine besylate. Int J App Pharm. 2019;11(4):132–139.
  • Munija P, Srikanth G. Formulation and evaluation of sumatriptan immediate-release tablets. J Drug Delivery Ther. 2018;8(5):241–247.
  • Divya L, Ravichandran V, Lavakumar V, et al. Preparation and evaluation of fluoxetine hydrochloride oral dispersible tablets. Int J Pharm Pharm Sci. 2014;6(2):216–222.
  • Khirwadkar P, Dashora K. Formulation and evaluation of fast dissolving tablet of the antidepressant drug by a novel approach. J Pharm Biol Sci. 2016;4(6):170–178.
  • Momin S, Khan S, Ghadage D, et al. Formulate and evaluate bilayer tablets of propranolol hydrochloride. J Drug Deliv Ther. 2017;7(2):50–57.
  • Lachman L, Liberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Mumbai (India): Varghese Publishing House; 1987. p. 296–303.
  • Reddy BV, Navaneetha K. Formulation and evaluation of orodispersible tablets of candesartan. Pharm Innov J. 2015;4(1):25–32.
  • Prakash GA, Bhagavansing RR. Formulation and evaluation of taste mask orally dispersible paracetamol tablet. J Drug Deliv Ther. 2016;6(2):30–36.
  • Baliga S, Muglikar S, Kale R. Salivary pH: a diagnostic biomarker. J Indian Soc Periodontol. 2013;17(4):461–465.
  • Nareda M, Sharma AK, Nareda S, et al. Design and formulation of fast dissolving tablet of lornoxicam using banana powder as natural super disintegrant by direct compression method. World J Pharm Pharm Sci. 2018;7(2):631–642.
  • Sharma P, Tailang M. In-vivo study of orodispersible tablet of primaquine. Int J Pharm Sci Res. 2018;9(8):3506–3510.
  • Reem N, Hebatalla A, Ekram N. Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: impact on oxidative stress, inflammation, apoptosis and monoamine levels. NeuroToxicology. 2014;44:48–57.
  • Das SK, Barhwal K, Hota SK, et al. Disrupting monotony during social isolation stress prevents early development of anxiety and depression like traits in male rats. BMC Neurosci. 2015;16(2):2–13.
  • Zimcikova E, Simko J, Karesova I, et al. Behavioral effects of antiepileptic drugs in rats: are the effects on mood and behavior detectable in open-field test? Seizure. 2017;52:35–40.
  • Sadeghi M, Peeri M, Hosseini MJ. Adolescent voluntary exercise attenuated hippocampal innate immunity responses and depressive-like behaviors following maternal separation stress in male rats. Physiol Behav. 2016;163:177–183.
  • Thakkar V, Shaikh Y, Soni T, et al. Design and evaluation of a sustained release enteric coated dosage form of fluoxetine hydrochloride. Ind J Pharm Edu Res. 2012;46(4):330–339.
  • Shekh I, Gupta V, Jain A, et al. Preparation and characterization of B- cyclodextrin aspirin inclusion complex. Int J Pharm & Life Sci. 2011;2(4):704–710.
  • Poornima KN, Deveswaran R, Bharath S, et al. Synthesis and evaluation of β-cyclodextrin-epichlorohydrin inclusion complex as a pharmaceutical excipient. J Fundam and Appl Sci. 2015;7(2):203–221.
  • Rabadiya B, Thakkar V, Rabadiya P. Drug-excipients interaction and solubility enhancement study of simvastatin. Int J Pharm Res Bio-Sci. 2013;2(1):168–185.
  • Ampati S, Hanumakonda A, Maheshwaram V. Formulation and evaluation of nasal in-situ gel of fluoxetine hydrochloride. Indo Am J Pharm Sci. 2016;3(6):573–581.
  • Selvam S, Balamuralitharan B, Karthick SN, et al. Novel high-temperature supercapacitor combined dye sensitized solar cell from sulfated β-cyclodextrin/PVP/MnCO3 composite. J Mater Chem A. 2015;3(19):10225–10232.
  • Bonenfant D, Niquette P, Mimeault M, et al. Adsorption study of a commonly used antidepressant drug, fluoxetine hydrochloride, onto a crosslinked β-cyclodextrin-carboxymethylcellulose polymer. Water Sci Technol. 2012;66(1):224–230.
  • Ghorpade V, Dias RJ, Mali KK, et al. Preparation and evaluation of domperidone/β-cyclodextrin/citric acid/mannitol quaternary inclusion complex: an in-vitro study. Asian J Pharm. 2016;10(3):375–385.
  • Swamy SK, Arun G, Sriniva B, et al. Effect of various superdisintegrants on the drug release profile of orally disintegrating tablets. Asian Jour Pharm and Technol. 2016;6(2):99–105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.